Transcriptional and translational modulation of KAI1 expression in ductal carcinoma of the breast and the prognostic significance

International Journal of Molecular Medicine

Volumn 23, Issue 2, 2009, Pages 273-278

  Malik, Fraz A ^a,b   Sanders, Andrew J ^a   Jones, Anthony Douglas ^a   Mansel, Robert E ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b Department of Electrical Computer Engineering   (Pakistan)

Author keywords

Breast cancer; CD82; Ducal carcinoma; KAI1; Metastasis; Survival

Indexed keywords

CD82 ANTIGEN; CD82 PROTEIN, HUMAN; COMPLEMENTARY DNA;

ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; BREAST TUMOR; CANCER STAGING; COHORT ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MORTALITY; PATHOLOGY; PROTEIN SYNTHESIS; TUMOR CELL LINE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; COHORT STUDIES; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KANGAI-1 PROTEIN; NEOPLASM STAGING; PROGNOSIS; PROTEIN BIOSYNTHESIS; SURVIVAL RATE; TRANSCRIPTION, GENETIC;

EID: 64749084632     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000127     Document Type: Article

References (34)

1. Gaugitsch HW, Hofer E, Huber NE, Schnabl E and Baumruker T: A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur J Immunol 21: 377-383, 1991.
2. Ichikawa T, Ichikawa Y and Isaacs JT: Genetic factors and suppression of metastatic ability of prostatic cancer. Cancer Res 51: 3788-3792, 1991.
3. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268: 884-886, 1995.
4. Todeschini AR, Dos Santos JN, Handa K and Hakomori SI: Ganglioside GM2/ GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc Natl Acad Sci 105: 1925-1930, 2008.
5. Nydegger S, Khurana S, Krementsov DN, Foti M and Thali M: Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J Cell Biol 173: 795-807, 2006.
6. Odintsova E, Sugiura T and Berdeitchevski F: Attenuation of EGF receptor signalling by a metastasis suppressor, the tetraspanin CD82/KAI1. Curr Biol 10: 1009-1012, 2000.
7. Abe M, Sugiura T, Takahashi M, Ishii K, Shimoda M and Shirasuna K: A novel functions of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells. Cancer Lett 266: 163-170, 2008.
8. Jackson P, Ow K, Yardley G, Delprado W, Quinn DI, Yang JL and Russell PJ: Down-regulation of KAI1mRNA in localized prostate cancer and its bony metastases do not correlate with p53 over expression. Prostate Cancer Prostatic Dis 6: 174-181, 2003.
9. Stark AM, Tongers K, Maass N, Mehdorn HM and Held-Feindt J: Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 131: 191-198, 2005.
10. Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S and Geradts J: Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumours. Clin Cancer Res 11: 4357-4364, 2005.
11. Wang XY, Liu T, Zhu CZ, Li Y, Sun R, Sun CY and Wang AX: Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray. Chin J Cancer 24: 1091-1095, 2005.
12. Houle CD, Ding XY, Foley JF, Afshari CA, Barrett JC and Davis BJ: Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol 86: 69-78, 2002.
13. Tsutsumi S, Shimura T, Morinaga N, Mochiki E, Asao T and Kuwano H: Loss of KAI1 expression in gastric cancer. Hepatogastroenterology 52: 281-284, 2005.
14. Guan-Zhen Y, Ying C, Can-Rong N, Guo-Dong W, Jian-Xin Q and Jie-Jun W: Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer. Int J Exp Pathol 88: 175-183, 2007.
15. Sho M, Adachi M, Taki T, Hashida H, Konishi T, Huang CL, Ikeda N and Miyake M: Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 79: 509-516, 1998.
16. Farhadieh RD, Smee R, Ow K, Yang JL, Russell PJ, Crouch R, Jackson P and Jacobson IV: Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival. Cancer Lett 213: 91-98, 2004.
17. Jackson P, Rowe A and Grimm MO: An alternatively spliced KAI1 mRNA is expressed at low levels in human bladder cancers and bladder cancer cell lines and is not associated with invasive behaviour. Oncol Rep 18: 1357-1363, 2007.
18. Schindi M, Birner P, Bachtiary B, Breitenecker G, Selzer E and Oberhuber G: The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer. Anticancer Res 20: 4551-4555, 2000.
19. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mobel K and Mansel RE: Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer11: 781-791, 2003.
20. Lane J, Mansel RE and Jiang WG: Delta-6-desaturase and FAD3 expression in human breast cancer. Int J Mol Med 12: 253-257, 2003.
21. Son BH, Choi JS and Lee JH: Prognostic values of KAI1 and survivin expression in an infiltrating ductal carcinoma of the breast. Pathology 37: 131-136, 2005.
22. Liu FS, Dong JT, Chen JT, Hsieh YT, Ho ES and Hung MJ: Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Gynecol Oncol 78: 10-15, 2000.
23. Adachi M, Taki T, Ieki Y, Huang C-L, Higashiyama M and Miyake M: Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 56: 1751-1755, 1998.
24. Yang X, Wei L, Tang C, Slack R, Montgomery E and Lippman M: KAI1 protein is down-regulated during the progression of human breast cancer. Clin Cancer Res 6: 3424-3429, 2000.
25. Liu T, Wang X, Zhu C, Li Y, Sun C and Wang A: Expression of KAI1 protein in tissue microarray and its biological significances in patients with lung cancer. Chin J Lung Cancer 8: 116-119, 2005.
26. Malik FA, Kayani MA, Iqbal H, Jiang WG and Sadiq R: Characterization of coding region of metastasis suppressor genes KiSS1 and KAI-1 for germ line mutations in breast cancer patients. Gene Ther Mol Biol (In press).
27. Miyazaki T, Kato H, Shitara Y, Yoshikawa M, Tajima K, Masuda N, Shouji H, Tsukada K, Nakajima T and Kuwano H: Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer 189: 955-962, 2000.
28. He B, Liu L, Cook GA, Grgurevich S, Jennings LK and Zhang XA: Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin α6-mediated cell adhesion. J Biol Chem 280: 3346-3354, 2005.
29. Zijlstra A and Quigley JP: The DARC side of metastasis: Shining a light on KAI1-mediated metastasis suppression in the vascular tunnel. Cancer Cell 10: 177-178, 2006.
30. Odintsova E, Voortman J, Gilbert E and Berditchevski F: Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR. J Cell Sci 116: 4557-4566, 2003.
31. Cannon KS and Cresswell P: Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO J 20: 2443-2453, 2001.
32. Huang C I, Kohno N, Ogawa E, Adachi M, Taki T and Miyake M: Correlation of reduction in MRP-1/Cd9 and KAI1/Cd82 expression with recurrences in breast cancer patients. Am J Path 153: 973-983, 1998.
33. Yang X, Wei LL, Tang C, Slack R, Mueller S and Lippman ME: Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 61: 5284-5288, 2001
34. Malik F, Sanders AJ, Douglas-Jones A, Mansel RE and Jiang WG: Kai-1 is aberrant expressed in human breast cancer and its link with cancer invasiveness. Br J Cancer (In press).